Key facts for C9312
- Billing unit
- 0.01 MG
- Inj trabecte apotex, 0.01 mg
- OPPS payment rate
- $46.71
- no ASP limit; SI G, October 2026
- Practitioner MUE
- none published
- CMS publishes no MUE for this code
- NCCI exposure
- no PTP pairs
- Coverage articles
- 0
- none list this code
TL;DR
HCPCS C9312 is the Level II code for Injection, trabectedin (apotex), not therapeutically equivalent to j9362, 0.01 mg, billed per 0.01 MG. CMS publishes no ASP payment limit for it; hospital outpatient departments are paid separately under OPPS (status indicator G, $46.71 per billing unit in October 2026). With a 1 mg billing unit, a single administration can be hundreds of units; the unit count on the claim must equal the milligrams given, and rounding rules for partial units follow the contractor's guidance. Other HCPCS codes whose descriptor names trabectedin: J9362 (Yondelis from Janssen Products, LP). The OPPS crosswalk maps 1 NDC to it, sold as Evdi by Apotex Corp. No current Billing and Coding Article lists C9312, so coverage follows the FDA label, compendia and any applicable NCD.
Medicare payment: OPPS rate (no ASP limit)
C9312 does not appear in the October 2026 Part B ASP payment limit file. CMS pays it separately to hospital outpatient departments under OPPS with status indicator G in APC 0959, at a national unadjusted rate of $46.71 per 0.01 MG. Status G is drug pass-through payment, which lasts a limited number of years. In a physician office the Medicare contractor prices the drug, often from invoice; commercial and Medicaid payers set their own rates.
NDC to HCPCS billing-unit conversion
The October 2026 OPPS crosswalk maps 1 NDC from 1 labeler to C9312. Report the NDC in the claim's drug segment and bill the number of C9312 units that equals the quantity administered divided by 0.01 MG; the last column gives units per full package.
| NDC | Drug name | Labeler | Package size | Billing units / package |
|---|---|---|---|---|
| 60505-6423-00 | Evdi | Apotex Corp | 20 × 1 | 100 |
Medically Unlikely Edits (MUE)
CMS does not publish an MUE for C9312 in the 2026 Q4 tables. Some MUE values are confidential and applied without publication, so unit limits can still deny; document the dose and the units calculation on every claim.
MUE for C9312 in every setting opens the lookup with this code filled in, next to any other code on the same claim.
NCCI edits and add-on relationships
No active practitioner PTP pair lists C9312 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.
The counts above are exposure, not answers for a specific claim. Check C9312 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.
C9312 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.
Medicare coverage articles
No current Billing and Coding Article lists C9312 in its HCPCS table. Coverage then follows the drug's FDA label, compendia and any National Coverage Determination; check the Medicare Coverage Database before administering off-label.
Hospital outpatient (OPPS) status
In the October 2026 OPPS Addendum B, C9312 carries status indicator G and is assigned to APC 0959, with a published national unadjusted payment of $46.71. Status G marks pass-through drug payment, which is time-limited.
Ambulatory surgical center (ASC) payment
In the October 2026 ASC Addendum BB (covered ancillary services), C9312 carries payment indicator K2, which CMS defines as "Drugs, biologicals, and radiopharmaceuticals paid separately when provided integral to a surgical procedure on ASC list; payment based on OPPS rate". The national ASC payment is $46.71 per 0.01 MG, paid only when the drug is furnished integral to a covered surgical procedure.
Common denials for C9312 and how to prevent them
For teams evaluating QuickIntell software
Evaluate a coding workflow for C9312
Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.
Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.
In QuickIntell research
- October 2026 HCPCS update report: C9312 was added in the October 2026 HCPCS update.
- J codes by drug name: Every code for the same drug, generic or brand, in one A-Z index.
Frequently asked questions — HCPCS C9312
What does HCPCS code C9312 describe?
C9312 is defined by CMS as "Injection, trabectedin (apotex), not therapeutically equivalent to j9362, 0.01 mg". Each billing unit represents 0.01 MG, so the units reported on the claim must equal the dose administered divided by that unit.
Is C9312 a CPT code?
No. C9312 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as trabectedin (Evdi); CPT codes are five-character codes maintained by the AMA. On a Part B claim C9312 reports the drug itself in 0.01 mg units, and the administration is billed on its own line.
What does Medicare pay for C9312 in a hospital outpatient department?
C9312 has no Part B ASP limit; the October 2026 OPPS Addendum B pays it separately under status G, APC 0959, at $46.71 per 0.01 MG, and ASC Addendum BB gives it payment indicator K2 at $46.71.
Which NDCs map to C9312?
The October 2026 OPPS crosswalk lists 1 NDC from 1 labeler: Evdi (Apotex Corp). For example NDC 60505-6423-00 (package size 20) equals 100 billing units of C9312.
Does C9312 have NCCI bundling edits?
No active practitioner PTP pairs list C9312 as a column-1 or column-2 code in the v323r0 release.
C9312 vs J9362: what is the difference?
Both are HCPCS Level II codes whose descriptor names trabectedin. What sets J9362 apart: Yondelis from Janssen Products, LP. C9312 is billed per 0.01 mg, OPPS rate $46.71; J9362 is billed per 0.01 mg, limit $41.844. Report the code whose descriptor matches the product and setting in the record.
Sources
Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.
- HCPCS Level II alpha-numeric file, October 2026Version October 2026 · effective 2026-10-01 · file HCPC2026_OCT_ANWEB_09232026.txtSHA-256 c25240c63108756d…
- OPPS Addendum B, October 2026Version October 2026 · effective 2026-10-01 · file 508-compliant-version-2026_October_Web_Addendum_B.09.28.26.csvSHA-256 6ad7393a318bf1b9…
- OPPS NDC-HCPCS crosswalk, October 2026Version October 2026 · effective 2026-10-01 · file section 508 version of October 2026 OPPS NDC-HCPCS Crosswalk 090426.csvSHA-256 167efe9e47c42718…
- NCCI MUE table, practitioner services, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file MCR_MUE_PractitionerServices_Eff_10-01-2026.csvSHA-256 ef038efaf902b7bd…
- NCCI MUE table, facility services, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file MCR_MUE_OutpatientHospitalServices_Eff_10-01-2026.csvSHA-256 3af9f4e99cc587e2…
- NCCI MUE table, dme services, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file MCR_MUE_DMESupplierServices_Eff_10-01-2026.csvSHA-256 6fa4fbba852f7b74…
- NCCI PTP edits, practitioner, v323r0 (four files)Version v323r0 (2026 Q4) · effective 2026-10-01 · file ccipra-v323r0-f1.TXTSHA-256 7793c0b6686c1e22…
- NCCI Add-On Code edits, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file AOC_V2026Q4-F-MCR.xlsxSHA-256 eabb519623134549…
- ASC Addendum BB (covered ancillary services), October 2026Version October 2026 · effective 2026-10-01 · file Oct 2026 ASC BB.txtSHA-256 63cdd7c72aba7a25…
- Medicare Coverage Database, current Billing and Coding Articles exportVersion MCD release 2026-11-12 · effective 2026-11-08 · file article.csvSHA-256 b475751458564786…
Disclaimer
This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.
Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.